Endovascular Engineering, Inc. ("E2") has secured $42 million in an oversubscribed Series B financing to advance its next generation clot removal technology platform for venous thromboembolism (VTE).
EnCharge AI, a startup developing first-of-its-kind analog in-memory-computing AI chips, has secured over $100 million in Series B funding. This latest oversubscribed round, which brings EnCharge AI's total funding to more than $144 million, will advance the commercialization of its first client computing-focused AI accelerator products in 2025 and progress along EnCharge’s future product roadmap.
Stellaromics, a pioneer in 3D spatial biology spun out of the laboratories of Karl Deisseroth (Stanford University) and Xiao Wang (MIT and Broad Institute), announced the completion of a Series B funding round for $80Mn.
Epicore Biosystems (Epicore), a digital health solutions leader developing advanced sweat-sensing wearables, has raised $26M in Series B funding led by the Steele Foundation for Hope (SFFH). The funding will help Epicore drive global adoption of its personalized hydration and cloud analytics platform and expand into new biomarker targets relevant to kidney health, women's health, malnutrition and environmental toxin exposures.
Urban Sky, a stratospheric platform company, has closed a $30M Series B investment round. The funding will be used to develop and commercialize a connected suite of products that will unlock the full value of the tactical stratosphere for military and commercial customers.
Fay, a leader in digital nutritional therapy, has raised $50 million Series B funding round led by Goldman Sachs at a $500 million valuation. Existing investors General Catalyst and Forerunner also participated in the round.
OneVest, a comprehensive wealth management technology platform, today announced the closure of a $20 million USD Series B equity funding round. The round was led by Salesforce Ventures, with participation from new investors, Allianz Life Ventures and TIAA Ventures. Returning investors include OMERS Ventures, Deloitte Ventures, Fin Capital, Luge Capital, and Pivot Investment Partners.
Data copilot company Prophecy announced a $47 million in Series B extension to accelerate the AI-powered transformation of the data integration market. Smith Point Capital led the round, with HSBC joining as a new investor and participation from existing investors including Berkeley SkyDeck, DallasVC, Insight Partners, JPMorgan Chase and SignalFire.
Leading epigenome editing company Tune Therapeutics (Tune) announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Pleno, a clinical and multi-omics diagnostics company that is revolutionizing biological target detection, today announced the appointment of Dr. Vik Vaz M.D. as its new chief executive officer and to serve on its Board of Directors, effective immediately.
